Apollomics, Inc.

For profitWebsite ↗

Also known as: Apollomics Inc. | CBT Pharmaceuticals (Australia) Pty Ltd | CBT Pharmaceuticals, Inc. | EVP and Chief Operating Officer, CBT Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 27, 2017

Last known activity

May 20, 2022

Timeline

2010s

Jan 1, 2016
Apollomics, Inc.— Founded

Drugs by trial phase (9 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

uproleselan

Phase 2 (4 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (13)

NCT05367388Study directorPhase 1May 20, 2022
NCT05367388Lead sponsorPhase 1May 20, 2022
NCT04743505CollaboratorPhase 1/Phase 2Nov 30, 2021
NCT05054543Lead sponsorPhase 3Oct 18, 2021
NCT05055518Lead sponsorPhase 1Aug 2, 2021
NCT04839341Lead sponsorPhase 1Feb 24, 2021
NCT03655613CollaboratorPhase 1/Phase 2Sep 5, 2018
NCT03655613Study chairPhase 1/Phase 2Sep 5, 2018
NCT03655613Lead sponsorPhase 1/Phase 2Sep 5, 2018
NCT03175224Lead sponsorPhase 1Jun 1, 2017
NCT03175224Study directorPhase 1Jun 1, 2017
NCT03053466Lead sponsorPhase 1Mar 27, 2017
NCT03053466Study directorPhase 1Mar 27, 2017

Details

Founded: Pleasanton, CA, US Jan 1, 2016
Last known activity: May 20, 2022

Notes

--- Pre-folding founded info: 2018-01-01 Foster City CA US https://www.globenewswire.com/news-release/2019/01/07/1681164/0/en/Apollomics-Inc-previously-CBT-Pharmaceuticals-Inc-Raises-100-Million-in-Series-B-Financing.html ---